How has been the historical performance of Rossari Biotech?

Answer:The historical performance of Rossari Biotech shows a consistent growth trajectory in net sales and profit over the years.

Breakdown:
Rossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025. This upward trend is mirrored in total operating income, which rose from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025. The company's operating profit (PBDIT) also demonstrated growth, climbing from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025. Profit before tax followed a similar pattern, increasing from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, while profit after tax rose from INR 65.25 crore to INR 136.38 crore over the same period. The company's total assets grew from INR 471.46 crore in March 2020 to INR 1,885.67 crore in March 2025, indicating a robust expansion in its asset base. Total liabilities also increased, from INR 471.46 crore to INR 1,885.67 crore, reflecting the company's growth strategy. Cash flow from operating activities improved significantly, reaching INR 137 crore in March 2025, compared to INR 56 crore in March 2020. Overall, Rossari Biotech has shown strong financial performance with increasing revenues, profits, and asset growth over the years.